LONDON: AstraZeneca Plc received more than US$1bil in US funding to develop a Covid-19 vaccine from the University of Oxford and said it has supply agreements for 400 million doses.
The UK drugmaker received the money from the US Biomedical Advanced Research and Development Authority (BARDA) and has secured capacity to make one billion doses, according to a statement from the Cambridge, England-based company.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!